• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

挪威一个卫生区域卵巢癌集中手术 10 年的经验。

Ten years' experience with centralized surgery of ovarian cancer in one health region in Norway.

机构信息

Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Norway.

出版信息

Int J Gynecol Cancer. 2012 Feb;22(2):226-31. doi: 10.1097/IGC.0b013e31823589ef.

DOI:10.1097/IGC.0b013e31823589ef
PMID:22080889
Abstract

BACKGROUND

Better outcome of advanced ovarian cancer after centralized surgery has led to the recommendation for centralized surgery in a Norwegian health region. Whether the practice pattern has changed according to this recommendation has not been examined.

OBJECTIVE

The objective of this study was to evaluate the referral practice and treatment of ovarian cancer in a Norwegian health region after the introduction of centralized surgery.

METHODS

This was a retrospective, population-based study, including all women undergoing surgery for primary ovarian, tubal, and peritoneal cancer between 2000 and 2005, in Health Region IV of Norway. Clinical data and data regarding treatment and 5-year follow-up were analyzed.

RESULTS

In total, 279 cases of ovarian, peritoneal, and tubal cancer were included. Eighty-four percent underwent primary surgery at the teaching hospital and 16% at the nonteaching hospitals. After an immediate rise in the number of cases undergoing primary surgery at the teaching hospital after the introduction of centralization in 1995, the percentage distribution between the teaching and nonteaching hospitals was stable during the study period. The women who underwent surgery at the nonteaching hospitals had a higher percentage of early-stage disease and were at higher risk of reoperation for comprehensive staging.

CONCLUSIONS

Centralization of ovarian cancer surgery has been successfully accomplished in a health region in Norway. The referral practice of assumed advanced ovarian cancer cases shows satisfactory compliance with centralization at 10 years after the implementation of centralized surgery.

摘要

背景

集中手术可提高晚期卵巢癌的治疗效果,因此挪威的一个卫生区域推荐进行集中手术。但是否根据该建议改变了手术实践模式尚未进行研究。

目的

本研究旨在评估挪威一个卫生区域在实施集中手术之后卵巢癌的转诊实践和治疗情况。

方法

这是一项回顾性的基于人群的研究,纳入了 2000 年至 2005 年间在挪威第四卫生区域内接受原发性卵巢癌、输卵管癌和腹膜癌手术的所有女性。分析了临床数据以及治疗和 5 年随访数据。

结果

共纳入 279 例卵巢癌、腹膜癌和输卵管癌患者。84%的患者在教学医院接受了原发性手术,16%的患者在非教学医院接受了原发性手术。1995 年集中化后,教学医院接受原发性手术的病例数立即增加,此后,在研究期间,教学医院和非教学医院之间的病例分布百分比保持稳定。在非教学医院接受手术的女性中,早期疾病的比例更高,且进行全面分期再手术的风险更高。

结论

在挪威的一个卫生区域成功实施了卵巢癌手术的集中化。10 年集中手术实施后,假设的晚期卵巢癌病例的转诊实践与集中化具有良好的一致性。

相似文献

1
Ten years' experience with centralized surgery of ovarian cancer in one health region in Norway.挪威一个卫生区域卵巢癌集中手术 10 年的经验。
Int J Gynecol Cancer. 2012 Feb;22(2):226-31. doi: 10.1097/IGC.0b013e31823589ef.
2
Prognostic value of histological type in stage IV ovarian carcinoma: a retrospective analysis of 223 patients.IV期卵巢癌组织学类型的预后价值:223例患者的回顾性分析
Br J Cancer. 2015 Apr 14;112(8):1376-83. doi: 10.1038/bjc.2015.97. Epub 2015 Mar 24.
3
Primary epithelial ovarian carcinoma in Taiwanese women.台湾女性原发性上皮性卵巢癌。
Eur J Gynaecol Oncol. 2001;22(1):57-60.
4
Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.在日常实践中,FIGO 分期 IIIC 至 IV 期卵巢、输卵管和腹膜癌患者的最大减瘤术:一项回顾性法国多中心研究。
Int J Gynecol Cancer. 2012 Oct;22(8):1337-43. doi: 10.1097/IGC.0b013e31826a3559.
5
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.不同组织学类型和疾病分期的浸润性上皮性卵巢癌生存情况。
J Natl Cancer Inst. 2019 Jan 1;111(1):60-68. doi: 10.1093/jnci/djy071.
6
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.激素受体表达与卵巢癌生存:卵巢肿瘤组织分析联盟研究。
Lancet Oncol. 2013 Aug;14(9):853-62. doi: 10.1016/S1470-2045(13)70253-5. Epub 2013 Jul 9.
7
Ovarian Carcinoma: A Single-Centre Eight-Year Case-Series Study with Survival Analysis.卵巢癌:单中心 8 年病例系列研究及生存分析。
Chirurgia (Bucur). 2024 Aug;119(4):373-384. doi: 10.21614/chirurgia.3025.
8
Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome.高肿瘤负荷的卵巢癌患者的最大努力细胞减灭术:实践中的差异及其对结局的影响。
Ann Surg Oncol. 2019 Sep;26(9):2943-2951. doi: 10.1245/s10434-019-07516-3. Epub 2019 Jun 26.
9
Associations between residual disease and survival in epithelial ovarian cancer by histologic type.不同组织学类型上皮性卵巢癌中残余病灶与生存的相关性。
Gynecol Oncol. 2017 Nov;147(2):250-256. doi: 10.1016/j.ygyno.2017.08.003. Epub 2017 Aug 16.
10
Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.FIGO IIIC期和FIGO IIIA1期卵巢癌患者初次肿瘤完全减灭术后的淋巴结受累模式及生存差异:肿瘤库卵巢癌网络的10年回顾性分析
Ann Surg Oncol. 2016 Apr;23(4):1279-86. doi: 10.1245/s10434-015-4959-4. Epub 2016 Jan 29.

引用本文的文献

1
Variation in ovarian cancer care in Australia: An analysis of patterns of care in diagnosis and initial treatment in New South Wales.澳大利亚卵巢癌治疗的差异:新南威尔士州诊断和初始治疗中治疗模式的分析。
Eur J Cancer Care (Engl). 2022 Nov;31(6):e13649. doi: 10.1111/ecc.13649. Epub 2022 Jul 3.
2
New Analytical Approach for the Alignment of Different HE4 Automated Immunometric Systems: An Italian Multicentric Study.不同HE4自动化免疫分析系统校准的新分析方法:一项意大利多中心研究。
J Clin Med. 2022 Apr 2;11(7):1994. doi: 10.3390/jcm11071994.
3
Stacking Machine Learning Algorithms for Biomarker-Based Preoperative Diagnosis of a Pelvic Mass.
堆叠机器学习算法用于基于生物标志物的盆腔肿块术前诊断
Cancers (Basel). 2022 Mar 2;14(5):1291. doi: 10.3390/cancers14051291.
4
What underlies the observed hospital volume-outcome relationship?观察到的医院量效关系的基础是什么?
BMC Health Serv Res. 2022 Jan 14;22(1):70. doi: 10.1186/s12913-021-07449-2.
5
Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care.探讨卵巢癌治疗的国际差异:临床实践指南与治疗模式比较。
Int J Gynecol Cancer. 2020 Nov;30(11):1748-1756. doi: 10.1136/ijgc-2020-001403. Epub 2020 Aug 11.
6
Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?多种生物标志物算法预测盆腔肿块女性的上皮性卵巢癌:是否有额外的标志物可以改善性能?
Gynecol Oncol. 2019 Jul;154(1):150-155. doi: 10.1016/j.ygyno.2019.04.006. Epub 2019 Apr 13.
7
Enhancing ovarian cancer care: a systematic review of guideline adherence and clinical variation.改善卵巢癌护理:对指南依从性和临床差异的系统评价
BMC Public Health. 2019 Mar 12;19(1):296. doi: 10.1186/s12889-019-6633-4.
8
Optimization of surgical treatment of advanced ovarian cancer: a Spanish expert perspective.优化晚期卵巢癌的外科治疗:西班牙专家观点。
Clin Transl Oncol. 2019 May;21(5):656-664. doi: 10.1007/s12094-018-1967-4. Epub 2018 Oct 30.
9
Being treated in higher volume hospitals leads to longer progression-free survival for epithelial ovarian carcinoma patients in the Rhone-Alpes region of France.在法国罗纳-阿尔卑斯地区,上皮性卵巢癌患者在规模较大的医院接受治疗可获得更长的无进展生存期。
BMC Health Serv Res. 2018 Jan 4;18(1):3. doi: 10.1186/s12913-017-2802-2.
10
The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database.时间对上皮性卵巢癌(OVCA)诊断分期的种族差异的影响,总体情况及按组织学亚型分析:一项基于国家癌症数据库的研究
Cancer Causes Control. 2016 Oct;27(10):1261-71. doi: 10.1007/s10552-016-0806-6. Epub 2016 Sep 2.